Navigation Links
The New York Stem Cell Foundation announces new initiative for Parkinson's disease
Date:6/22/2011

NEW YORK CITY (June 22, 2011)The New York Stem Cell Foundation (NYSCF) has received a half-million dollar gift from the Golub family to launch the NYCF-Golub Stem Cell Initiative for Parkinson's Disease. The initiative permits researchers in the NYSCF Laboratory to use a novel approach to understand Parkinson's disease that includes the creation of stem cell lines from a genetically diverse population of Parkinson's patients.

The announcement was made at the NYSCF Laboratory by the organization's CEO Susan L. Solomon, NYSCF Board Chairman Dr. Roy Geronemus, and Lawrence E. Golub, President of Golub Capital, and his wife Karen Finerman, President and CEO of Metropolitan Capital Advisors.

According to Ms. Solomon, the NYSCF Golub Initiative provides a remarkable opportunity to advance the search for better therapies for Parkinson's disease, and supports a dedicated team of Parkinson's researchers in the NYSCF Laboratory. The research will include creating stem cell lines from a genetically diverse population of Parkinson's patients, which will be part of a large bank of lines that will greatly accelerate the creating of new drugs and therapies on actual cells that are dying of the disease. It will permit NYSCF researchers and their collaborators to screen for drugs that slow or stop the progression of Parkinson's disease.

"We are so grateful to Lawrence Golub and Karen Finerman for their generous support of a new approach that holds so much promise for this debilitating disease that creates so much suffering for patients and their families," says Ms. Solomon. "This is an incredible opportunity to advance the search for better treatments for Parkinson's disease. The current therapies are just not acceptable."

"Our goal is to accelerate treatments and translational work that pharmaceutical companies are not prepared to do," said Mr. Golub, who explains the lines will be made available to qualified private and public sector scientists for research purposes. "NYSCF has the right people and the right lab to get the job done. Our goal is to create a drug-testing factory that turns raw science into drugs for the public sector."


'/>"/>

Contact: Nadine Woloshin
nwoloshin@rubenstein.com
212-843-8041
New York Stem Cell Foundation
Source:Eurekalert

Related medicine news :

1. Damon Runyon Cancer Research Foundation awards $3.45 million to 9 top young clinical investigators
2. SIR Foundation sets research priorities for minimally invasive treatments for MS patients
3. Lymphoma Research Foundation and John Theurer Cancer Center collaborate for Lymphoma Rounds program
4. Outstanding high school students receive AGA Research Foundation Fellowship Awards
5. The New York Stem Cell Foundation awards fellowships to 7 innovative stem cell scientists
6. MetLife Foundations grant bolsters media coverage for aging issues
7. John Theurer Cancer Center and the Promise Foundation partner to offer free skin cancer screenings
8. Cole Foundation injects $700,000 into childhood cancer research
9. Cedars-Sinais mobile medical clinics receive $500,000 grant from California Community Foundation
10. Gates Foundation awards Ben-Gurion U. researcher grant for malaria detection using cell phones
11. AACR and Landon Foundation support the next generation of researchers with INNOVATOR Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... 2017 , ... Thinksport, the most award-winning sunscreen on the ... Marin. For the second year in a row, cyclists will stay protected from ... thrilled to provide our safe, non-toxic sunscreen to over 2,000 cycling enthusiasts again ...
(Date:2/23/2017)... ... 2017 , ... Rare Disease Report®, which is the only ... Disease Day events, hosted by the Rare Disease Legislative Advocates (RDLA) on February ... e-newsletter and quarterly publication, will be conducting interviews with patients and advocates in ...
(Date:2/23/2017)... ... 23, 2017 , ... Rosica Communications, a national PR ... media management, corporate communications, SEO and cause marketing, is opening an office in ... Hampshire, Massachusetts and Canada, Rosica will focus on expanding its footprint. , ...
(Date:2/23/2017)... Denver, Colorado (PRWEB) , ... February 23, 2017 ... ... Dialog Magazine, an exciting, new, interactive publication where generations converge and explore the ... to expand their worldview, Dialog Magazine enables readers to gain understanding, increase empathy, ...
(Date:2/23/2017)... ... 23, 2017 , ... The Center for Autism and Related ... Autism Research and Treatment (RI-CART) and Cinemaworld to present Sensory Friendly Films. The ... see films in an environment that accommodates their unique needs. , Launched in ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... NEW YORK , Feb. 23, 2017  Genesis ... HME Company. The announcement was made by Bill ... David Hartley and Nathan Feltman , ... of Genesis Healthcare Services, LLC. This ... nation,s largest provider of technology enabled durable medical equipment ...
(Date:2/23/2017)... Feb. 23, 2017 Nevro Corp. (NYSE: NVRO), a ... for the treatment of chronic pain, today reported financial results ... 2016. 2016 Accomplishment & Highlights: ... 2016, an increase of 228% as reported, over the prior ... an increase of 612% over the prior year ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... to their offering. ... The latest research Fibromyalgia Drugs Price Analysis and Strategies - ... market. The research answers the following questions: ... their clinical attributes? How are they positioned in the Global Fibromyalgia ...
Breaking Medicine Technology: